Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Lerapolturev vs Lomustine in Recurrent Glioblastoma
NCT06177964Phase 2Recruiting
- Sponsor
- Istari Oncology
- Start
- Jul 2024
- Primary completion
- Feb 2029
- Modality
- Oncolytic Viruses, Vaccines & Immunotherapeutics
- Countries
- 1
01
Overview
A Phase 2 trial of lerapolturev in glioblastoma (GBM), sponsored by Istari Oncology. Started Jul 2024; status: recruiting.
02
Drugs
lerapolturev
03
Conditions
glioblastoma (GBM)
Beyond the preview
Go deeper on NCT06177964.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT06177964.